CLASS III ONGOING Device recall · Reported 19 Nov 2025 · FDA Enforcement Report

VerifyNow PRUTest Platelet Reactivity Test recalled

Accriva Diagnostics is recalling VerifyNow PRUTest Platelet Reactivity Test, distributed nationwide in the US. The recall was initiated on 21 Oct 2025 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesCatalog Number: 85225 UDI-DI code: 10711234150078 Lot Number: WP1559-01
Quantity recalled125 boxes (3,125 tests)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0500-2026
FDA event ID
97863
Recalling firm
Accriva Diagnostics, San Diego, CA
Classification
Class III
Status
Ongoing
Recall initiated
21 Oct 2025
FDA classified
13 Nov 2025
Reported
19 Nov 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

21 Oct 2025Recall initiated by company
13 Nov 2025Classified by FDA+23 days
19 Nov 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to an device without a premarket clearance being incorrectly package and distributed.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood test used in the laboratory or point of care setting to measure the level of platelet P2Y12 receptor blockade.

Where it was distributed

Worldwide - U.S. Nationwide distribution in the states of AK, CA, FL, IA, IL, MD, MI, NY, SD, and TX. The countries of Hong Kong, Japan.

Nationwide AlaskaCaliforniaFloridaIowaIllinoisMarylandMichiganNew YorkSouth DakotaTexas

Questions about this recall

Why was it recalled?

Due to an device without a premarket clearance being incorrectly package and distributed.

Which lots are affected?

Catalog Number: 85225 UDI-DI code: 10711234150078 Lot Number: WP1559-01

Where was it sold?

Worldwide - U.S. Nationwide distribution in the states of AK, CA, FL, IA, IL, MD, MI, NY, SD, and TX. The countries of Hong Kong, Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Accriva Diagnostics

All 6

Other Other Medical Devices recalls

All 13,908